Patient attitudes and preferences about expanded noninvasive prenatal testing
Introduction: Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about...
Main Authors: | Marie-Line Dubois, Patricia D. Winters, Marc-André Rodrigue, Jean Gekas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.976051/full |
Similar Items
-
Concordance analysis between noninvasive prenatal testing (NIPT) and prenatal karyotyping for detecting fetal aneuploidies
by: Diana Carolina Grajales-Ospina, et al.
Published: (2022-04-01) -
Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium
by: Erica Soster, et al.
Published: (2024-04-01) -
Clinical Application of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies in Central China
by: Ganye Zhao, et al.
Published: (2022-01-01) -
Clinical evaluation of noninvasive prenatal testing for sex chromosome aneuploidies in 9,176 Korean pregnant women: a single-center retrospective study
by: Hyunjin Kim, et al.
Published: (2024-01-01) -
Maternal and fetal factors influencing fetal fraction: A retrospective analysis of 153,306 pregnant women undergoing noninvasive prenatal screening
by: Cechuan Deng, et al.
Published: (2023-04-01)